Intereferon_and_cancer_cells.png (800 × 347 pixels, file size: 282 KB, MIME type: image/png)
![]() | This is a file from the Wikimedia Commons. Information from its description page there is shown below. Commons is a freely licensed media file repository. You can help. |
Summary
DescriptionIntereferon and cancer cells.png |
English: Interferon-α/β (IFN-α/β) has direct effects in tumor cells inducing growth arrest and cell death (left panel). After binding to the heterodimeric IFN-α/β receptor 1 and 2 (IFNAR1/IFNAR2), type I IFNs induce a cascade of intracellular events which culminates in expression of genes whose promoters contain the IFN-stimulated response element (ISRE). In this way, several immuno-regulatory cytokines, cell death factors and proteins related to antiviral response are produced, as well as more IFN-α/β, which in turn affects neighboring cells. In addition, anti-tumor effects of type I IFN may also be a consequence of its anti-angiogenic function, impairing tumor vessel formation and leading to death of tumors by lack of oxygen and nutrients (right panel). IFN-α/β can inhibit the production of angiogenic factors by tumor cells, and directly affects endothelial cells (EC), inhibiting their proliferation and secretion of factors responsible for EC chemotaxis and remodeling of extracellular matrix. Tyrosine kinase 2 (TYK2), Janus kinase 1 (JAK1), signal transducer and activator of transcription (STAT), IFN-regulatory factor 9 (IRF9), IFN-stimulated gene factor 3 (ISGF3), vascular endothelial growth factor (VEGF), basic fibroblast growth factor (bFGF), interleukin-8 (IL-8), platelet endothelial cell adhesion molecule-1 (PECAM-1), promyelocytic leukemia protein (PML), matrix metalloproteinase 9 (MMP9). |
Date | |
Source |
Oncotarget. 2017 Jul 25;8(41):71249-71284. Immunomodulatory and antitumor effects of type I interferons and their application in cancer therapy. http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=19531&path%5B%5D=62425 |
Author | Medrano RFV, Hunger A, Mendonça SA, Barbuto JAM, Strauss BE |
Licensing
![w:en:Creative Commons](https://upload.wikimedia.org/wikipedia/commons/thumb/7/79/CC_some_rights_reserved.svg/90px-CC_some_rights_reserved.svg.png)
![attribution](https://upload.wikimedia.org/wikipedia/commons/thumb/1/11/Cc-by_new_white.svg/24px-Cc-by_new_white.svg.png)
This file is licensed under the Creative Commons Attribution 3.0 Unported license.
- You are free:
- to share – to copy, distribute and transmit the work
- to remix – to adapt the work
- Under the following conditions:
- attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
![]() |
This file, which was originally posted to
https://www.oncotarget.com/article/19531/, was reviewed on 13 July 2021 by reviewer Wcam, who confirmed that it was available there under the stated license on that date.
|
Captions
Intrinsic anti-tumor and anti-angiogenic functions of type I interferons.
Items portrayed in this file
depicts
19 July 2017
File history
Click on a date/time to view the file as it appeared at that time.
Date/Time | Thumbnail | Dimensions | User | Comment | |
---|---|---|---|---|---|
current | 20:53, 1 February 2020 | ![]() | 800 × 347 (282 KB) | Olgamatveeva | User created page with UploadWizard |
File usage
The following pages on the English Wikipedia use this file (pages on other projects are not listed):
Metadata
This file contains additional information, probably added from the digital camera or scanner used to create or digitize it.
If the file has been modified from its original state, some details may not fully reflect the modified file.
Horizontal resolution | 37.79 dpc |
---|---|
Vertical resolution | 37.79 dpc |
Retrieved from "https://en.wikipedia.org/wiki/File:Intereferon_and_cancer_cells.png"